Zhitong Finance App News, Alice (688578.SH) issued an announcement. Recently, the company received the “Notice of Acceptance” approved and issued by the State Drug Administration. The marketing application for vometinib mesylate tablets (“vometinib”) submitted by the company for adjuvant treatment after tumor resection in adult patients with epidermal growth factor receptor (EGFR) exon 19 deficiency or exon 21 (L858R) replacement mutations was accepted.

Zhitong Finance App News, Alice (688578.SH) issued an announcement. Recently, the company received the “Notice of Acceptance” approved and issued by the State Drug Administration. The marketing application for vometinib mesylate tablets (“vometinib”) submitted by the company for adjuvant treatment after tumor resection in adult patients with epidermal growth factor receptor (EGFR) exon 19 deficiency or exon 21 (L858R) replacement mutations was accepted.